# Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis

> **NCT00117377** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 70 (—)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Pimecrolimus
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00117377
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** —
- **Final completion:** 2005-06
- **Target enrollment:** 70 (—)
- **Last updated:** 2007-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00117377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00117377, "Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00117377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*